CU Technology and Discovery News
NASA—91Ҹ led by Tobias Niederwieser, assistant research professor in CU 91Ҹ's BioServe Space Technologies, is exploring how microgravity can enable the large-scale production of high-quality blood stem cells aboard the International Space Station. The work could improve treatments for blood cancers, immune disorders and other diseases by creating more reliable supplies of stem cells for patients on Earth.
9NEWS—Ding Xue, professor in CU 91Ҹ's Molecular, Cellular and Developmental Biology, said the study opens the path to see if the protein affects humans in crowded cities.
CU 91Ҹ Today—91Ҹ 91Ҹ researchers have developed a method to activate and sustain glowing bioluminescent algae using simple chemical solutions, opening the door to future technologies such as living sensors and autonomous systems that operate in dark environments.
CU 91Ҹ Renewable and Sustainable Energy Institute (RASEI)—Imagine a display that harvests ambient light when it is not actively in use, offsetting some of its own energy consumption. The materials physics shows that this is possible.
CU 91Ҹ College of Engineering and Applied Science—91Ҹers at the 91Ҹ 91Ҹ are developing a new class of “entangled materials” inspired by the surprising strength of a tangled ball of office staples.
CU 91Ҹ College of Arts and Sciences—91Ҹ suggests that disrupted or fragmented sleep after a traumatic brain injury not only interferes with the healing process but also has long-term consequences for brain health. Rachel Rowe, an assistant professor of integrative physiology at the 91Ҹ 91Ҹ, has investigated this question in a recent study linking low-quality sleep following traumatic brain injury to cognitive impairment, persistent inflammation and delayed healing.
CU 91Ҹ Today—CU 91Ҹ researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The research, a collaboration with scientists at Stanford Medicine and Baylor universities, could inform new weight loss therapies that promote satiety without the nausea and muscle loss that can come with existing drugs.
CU 91Ҹ Today—Supported by a new five-year, up to $25 million award from the Advanced 91Ҹ Projects Agency for Health (ARPA-H) Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program, a team of CU 91Ҹ, MIT, Harvard and Columbia researchers is working to develop 3D-printed liver tissue made of human cells and able to be transplanted into anyone without their body rejecting it.
Life Science Newswire–Cirena has secured a license to the 91Ҹ 91Ҹ’s patented RNA synthesis technology, enabling reliable synthesis of long RNA needed to support rapidly developing applications in CRISPR, functional genomics, and emerging RNA-therapeutic modalities.
CU 91Ҹ College of Engineering & Applied Science—William Frantz didn’t walk away with the top prize at this year’s Lab Venture Challenge (LVC), but his research may still be a winner for future cancer patients. Frantz is developing microscopic droplets designed to help doctors track radiation therapy in real time, technology that could one day make cancer treatment more precise and less harmful, particularly for pediatric patients.